The development and therapeutic potential of protein kinase inhibitors

被引：161

作者：

Cohen, P ^{[1
]}

机构：

[1] Univ Dundee, Dept Biochem, MRC, Prot Phosphorylat Unit, Dundee, Scotland

来源：

CURRENT OPINION IN CHEMICAL BIOLOGY | 1999年 / 3卷 / 04期

关键词：

D O I：

10.1016/S1367-5931(99)80067-2

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A number of small cell-permeant protein kinase inhibitors have been developed that have the potential for treating a variety of diseases. The basis for the specificity of several of these drugs has been elucidated and a number are undergoing human clinical trials.

引用

页码：459 / 465

页数：7

共 46 条

[1] Mechanism of activation and function of protein kinase B [J].

Alessi, DR ;

Cohen, P .

CURRENT OPINION IN GENETICS & DEVELOPMENT, 1998, 8 (01) :55-62

[2] The protein kinase C inhibitors Ro 318220 and GF 109203X are equally potent inhibitors of MAPKAP kinase-1 beta (Rsk-2) and p70 S6 kinase [J].

Alessi, DR .

FEBS LETTERS, 1997, 402 (2-3) :121-123

[3] PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO [J].

ALESSI, DR ;

CUENDA, A ;

COHEN, P ;

DUDLEY, DT ;

SALTIEL, AR .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) :27489-27494

[4]

Badger AM, 1996, J PHARMACOL EXP THER, V279, P1453

[5] Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB 203580 and PD 98059 -: SB 203580 also inhibits thromboxane synthase [J].

Börsch-Haubold, AG ;

Pasquet, S ;

Watson, SP .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (44) :28766-28772

[6]

BROWN DS, 1997, Patent No. 99151641

[7] CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins [J].

Carroll, M ;

OhnoJones, S ;

Tamura, S ;

Buchdunger, E ;

Zimmermann, J ;

Lydon, NB ;

Gilliland, DG ;

Druker, BJ .

BLOOD, 1997, 90 (12) :4947-4952

[8] The search for physiological substrates of MAP and SAP kinases in mammalian cells [J].

Cohen, P .

TRENDS IN CELL BIOLOGY, 1997, 7 (09) :353-361

[9] SB-203580 IS A SPECIFIC INHIBITOR OF A MAP KINASE HOMOLOG WHICH IS STIMULATED BY CELLULAR STRESSES AND INTERLEUKIN-1 [J].

CUENDA, A ;

ROUSE, J ;

DOZA, YN ;

MEIER, R ;

COHEN, P ;

GALLAGHER, TF ;

YOUNG, PR ;

LEE, JC .

FEBS LETTERS, 1995, 364 (02) :229-233

[10] Inhibition of cyclin-dependent kinases by purine analogues - Crystal structure of human cdk2 complexed with roscovitine [J].

DeAzevedo, WF ;

Leclerc, S ;

Meijer, L ;

Havlicek, L ;

Strnad, M ;

Kim, SH .

EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 243 (1-2) :518-526

← 1 2 3 4 5 →